In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
License agreement between Spectral Genomics and Affymetrix
Affymetrix Enters Into Licensing Deal With Empire Genomics - Quick Facts [AFFX]
Affymetrix and Eos in DNA array agremeent
U.S. Genomics Licenses Locked Nucleic Acid (LNA™) Chemistries from Exiqo
Affymetrix and Roche NimbleGen Expand Licensing Agreement
Affymetrix and Vita Genomics collaborate to develop microarray-based IVD products
SPECTRAL SIGNS EXCLUSIVE LICENSE AGREEMENT TO BRING SEPSIS THERAPEUTIC TO THE U.S. MARKET
Takara Shuzo to commercialize Affymetrix DNA arrays
Affymetrix signs license agreement with MWG-Biotech
EXIQON LICENSES LOCKED NUCLEIC ACIDTM TECHNOLOGY TO INVITROGEN FOR SAMPLE PREPARATION PRODUCTS